Fundraising FoxByers Capital
Venture capitalActively deployingFind your way into Byers Capital
Sign up to find every way you can get introduced to Byers Capital
- Your email: who you already know at Byers Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Byers Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
No fund details provided to summarize stages, differentiation, or concrete founder value-add.
What they invest in
from 13 of 15 portfolio companiesBiotech ×10AI & Machine Learning ×9Deep Tech ×4Healthtech ×3Developer Tools ×2Enterprise Software ×2Medical Devices ×2SaaS ×2
HQs:United States×11Netherlands×1
Investments · 15 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12021 · 12020 · 14 dated
Revolutionizing space technology to make life multi-planetary
Hawthorne, US
Elon Musk(Founder)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)Tom Mueller(Founder)
BoardAntonio Gracias(Director)inSteve Jurvetson(Director)in
Co-investors1/1 Capital137 Ventures1802 Ventures2080 Ventures3Spoke Capital4DX Ventures+203 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Bluebird VenturesCasdin CapitalEuropean Innovation Council Fund+7 more
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)
Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsLuma GroupOUP (Osage University Partners)SoftBank Vision Fund+3 more
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
Sajith Wickramasekara(Founder)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)
BoardMiles Grimshaw(Director)in
Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+30 more
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder)inJack Dent(Founder)inJacques Boitreaud(Founder)Jacques Boutreau(Founder)Joshua Meier Jack Dent(Founder)Matt McPartlon(Founder)
Co-investorsAmplify PartnersAvenir Growth CapitalBain Capital VenturesBattery VenturesDCVC (Data Collective)General Catalyst+29 more
.png)
Factory is an agent-native software development platform whose "Droid" agents plan, build, review, test, and ship production software across tools like the CLI, desktop, web, Slack, Microsoft Teams, Jira, Linear, and CI.
AI & Machine LearningDeveloper ToolsSaaSSan Francisco, US
Matan Grinberg(Founder)inEno Reyes(Founder)in
Co-investorsAbstract VenturesBBQ CapitalBoxGroupCoral CapitalGTM CapitalKhosla Ventures+16 more
Harmonic builds an advanced reasoning engine, a mathematical and computational tool for solving complex problems across scientific and technical domains.
AI & Machine LearningDeep Tech
Tudor Achim(Founder)inVlad Tenev(Founder)inVlad Tenev Tudor Achim(Founder)
Co-investorsBlossom CapitalFirestreak VenturesGreatPoint VenturesIndex VenturesKleiner PerkinsParadigm+8 more
Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
BiotechFremont, US
ELON MUSK(Executive Officer)inBen Rapoport(Founder)Benjamin Rapoport(Founder)DJ Seo(Founder)Dongjin Seo(Founder)Elon Musk(Founder)
Co-investors1802 VenturesAdvaita CapitalAliya Capital PartnersAurum Venture PartnersBeyond CapitalCraft Ventures+37 more
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.
AI & Machine LearningBiotechLongevitySouth San Francisco, US
Brian Armstrong(Founder)inBlake Byers(Founder)inJacob Kimmel(Founder)inMichael Polansky(Executive Officer)
BoardZavain Dar(Director)in
Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+15 more
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
Co-investors+ND CapitalARCH Venture PartnersBluebird VenturesCraft VenturesFounders FundParadigm+2 more
Kyle Vogt(Founder)inLuke Holoubek(Founder)Paril Jain(Founder)
Co-investorsSpark CapitalSV Angel
Vial develops first- and best-in-class biologic therapeutics — including RNA, antibody, and small molecule programs — for immunology and inflammatory disorders, using AI-driven target discovery and molecule design.
AI & Machine LearningBiotechHealthtech
Andrew Brackin(Founder)Simon Burns(Founder)
Co-investorsBoxGroupGeneral Catalyst
Vial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders.
AI & Machine LearningBiotechDigital HealthSan Francisco, US
Simon Burns(Founder)
Co-investorsATEL VenturesGeneral Catalyst
x.ai builds frontier AI reasoning models, real-time voice AI, and generative media systems.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwarePalo Alto, US
Yuhuai (Tony) Wu(Founder)inDennis Mortensen(Executive Officer, Director)Alex Poon(Director)Greg Yang(Founder)inGuodong Zhang(Founder)inIgor Babuschkin(Founder)in
Co-investors7percent VenturesAbstract VenturesAccess Ventures (New York)Aglae VenturesAmity VenturesAndreessen Horowitz+71 more
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US
Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Founder)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)Bob Nelsen(Founder)
Co-investorsARCH Venture PartnersBreyer CapitalDeviation CapitalF-Prime CapitalForesite CapitalLongwood Fund+5 more
Exits · 3
1 IPOs · 2 acquisitions · showing 2Portfolio news
latest coverage across their companiesChai Discovery · finsmes.com · Jul 14, 2026
Leyden Labs · techfundingnews.com · Jun 25, 2026
xAI · techcrunch.com · Jan 6, 2026
Harmonic · finsmes.com · Nov 26, 2025
Neuralink-LogoArtboard-1 · neuralink.com · Jun 2, 2025
Frequently asked questions
- How many investments has Byers Capital made?
- Byers Capital has 15 tracked investments, 3 of which have exited, including 1 dated in the last 24 months.
- What sectors does Byers Capital focus on?
- Byers Capital focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Robotics, Space Tech.
- Does Byers Capital lead rounds?
- Byers Capital typically participates in rounds rather than leading them.
Similar investors
BOLD Capital Partners is a venture capital firm that backs entrepreneurs and companies pursuing transformative science and technology aimed at disrupting and democratizing large markets and addressing major human challenges.
Divergent Capital is an early-stage venture firm backing multidisciplinary founders modernizing essential systems across physical (atoms), digital (bits), and biological (cells) domains.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.
Transpose Platform Management is a venture capital firm that backs founders and early-stage technology companies across a wide range of sectors, with a large portfolio weighted heavily toward AI-focused startups.
Radix Ventures is a deep tech venture capital firm founded in 2024 by experienced entrepreneurs and tech investors, focused on backing deep tech innovators across Central and Eastern Europe.